Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Semaglutide for Sale > Tirzepatide 99% white powder, glp-1, GIP, Bulk powder for Injection
Tirzepatide 99% white powder, glp-1, GIP, Bulk powder for Injection buy - large image1
Tirzepatide 99% white powder, glp-1, GIP, Bulk powder for Injection buy - image1

Tirzepatide 99% white powder, glp-1, GIP, Bulk powder for Injection

TDS 503 Inquiries

Unit Price: Get Latest Price
CAS No.:

910463-68-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Xiamen, Shanghai

Brand:

Top Health

Packaging:

10g/bottle, 100g/bottle, 10~1000g/bottle

Price valid (until):

2025-02-01

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptide,GLP-1,Semaglutide,Semaglutide Powder,910463-68-2,Semaglutide Pen Injector

  • Product Description

  • Seller Information

  • Inquiry History

  • Description
    Tirzepatide Chemical Properties
    storage temp.  Store at -20°C
    solubility  Soluble in DMSO



    Tirzepatide Usage And Synthesis
    Description Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
    Uses Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes.  Controlling high blood sugar helps prevent kidney damage, blindness,  nerve problems, loss of limbs, and sexual function problems.
    Mechanism of action It works to stimulate first- and second-phase insulin secretion, and reduces glucagon levels, both in a glucose-dependent manner.  Tirzepatide was also shown to delay gastric emptying, lower fasting and  postprandial glucose concentration, decrease food intake, 4 and reduce body weight in patients with type 2 diabetes.
    Pharmacology Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist that integrates the actions of both incretins into a single novel molecule. GIP is a hormone that may complement the effects of GLP-1 receptor agonists. In preclinical models, GIP has been shown to decrease food intake and increase energy expenditure therefore resulting in weight reductions, and when combined with GLP-1 receptor agonism, may result in greater effects on markers of metabolic dysregulation such as body weight, glucose and lipids. Tirzepatide is in phase 3 development for adults with obesity or overweight with weight-related comorbidity and is currently under regulatory review as a treatment for adults with type 2 diabetes. It is also being studied as a potential treatment for non-alcoholic steatohepatitis (NASH) and heart failure with preserved ejection fraction (HFpEF). Studies of tirzepatide in obstructive sleep apnea (OSA) and in morbidity/mortality in obesity are planned as well.
    Mode of action Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behaviour has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist. Signaling studies have shown that this is due to tirzepatide mimicking the actions of natural GIP at the GIP receptor. However, at the GLP-1 receptor, tirzepatide shows bias towards cAMP (a messenger associated with regulation of glycogen, sugar and lipid metabolism) generation, rather than β-arrestin recruitment. This combination of preference towards GIP receptor and distinct signaling properties at GLP-1 suggest this biased agonism increases insulin secretion. Tirzepatide has also been shown to increase levels of adiponectin, an adipokine involved in the regulation of both glucose and lipid metabolism, with a maximum increase of 26% from baseline after 26 weeks, at the 10 mg dosage.
    Clinical claims and research Tirzepatide , a novel, once-weekly injectable dual glucose-dependent insulinotropic polypeptide (GIP) receptor and GLP-1 RA combination drug, has been developed to treat patients with T2DM.
    Items Specifications
    Product name Tirzepatide
    Appearance

    White to off-whtite powerder or loose lumps.

    Packing 1g/Bottle or Customized


      Tirzepatide Purity>99%  USD295/g~USD335/g, according to your order quantity. 


    Certificates
    • Tirzepatide 99% white powder, glp-1, GIP, Bulk powder for Injection Certificates 1

    Basic Info
    Product Name:

    Semaglutide

    Other Name:

    semaglutide;Unknown (acetate);NN9535;Semaglutide [USAN:INN];Sermaglutide;NN 9535;NNC 0113-0217

    CAS No.:

    910463-68-2

    Molecular Formula:

    C187H291N45O59

    InChIKeys:

    DLSWIYLPEUIQAV-CCUURXOWSA-N

    Molecular Weight:

    4113.57754

    Exact Mass:

    4113.122087 g/mol

    Categories:

    Polypeptide

    Characteristics
    PSA:

    1650 Ų

    XLogP3:

    5.44520

    Hazard Identification

    Classification of the substance or mixture

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptide,GLP-1,Semaglutide,Semaglutide Powder,910463-68-2,Semaglutide Pen Injector

    Location:

    5 Floor, MouFu Building, HuLi Zone, Xiamen, Fujian, China.

    Payment Terms:

    TT against copy of documents,L/C,100% TT in advance

    Average lead Time:

    7

    Total Annual Revenue:

    $10 million-$25 million

    Total Employees:

    51-100

    Year of Establishment:

    2014

    Xiamen Top Health Biochem Tech. Co.,Ltd. was established in 2008 in Xiamen, China, and now has been a leading group specialized in custom developing, custom manufacturing and trading of Medicine, our products including but not limited to:
    Pharmaceutical raw mateiral)APIs
    pharmaceutical intermediates
    cosmetic raw materials
    herbal extracts
    health&food supplements
    finish dosage form(FDF)
    Animal Drug
    Pesticide
    Semaglutide and Tirzepatide

    We have 20 years experience of exporting to North America, South America, Euro, Middle East, Japan, Korea, Vietnam and other Asia countries, etc. 

    We have cooperated with local Medicine Inspection Center as our QC center. 

    We havecustomer manufacture sites managed under GMP guidline in Zhejiang and Jiangsu Province, China.

    We accepted audits both from end-users and from authorities like PMDA.

    We have good relationship with many pharmaceutical research Institute and Universities in China.

  • Inquiry History
    503 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Weight Loss Semaglutide intermediate 99% White powder COA High Quality peptide GLP-1 910463-68-2

    5 MG Apr 11, 2024
    United States

    Gene-Biocon Semaglutide 910463-68-2 GLP-1analogs diabetes weight loss 96% White or off-white powder

    Dec 5, 2023
    United States

    Semaglutide 910463-68-2

    1 G Sep 21, 2023
    China

    Semaglutide CAS 910463-68-2

    1 KG Apr 16, 2026
    United Kingdom

    Semaglutide 910463-68-2 Muhuang

    100 G Aug 18, 2023
    United States

    Sermaglutide 99% 910463-68-2

    2 KG Oct 21, 2023
    United Kingdom

    TGYFactory Supply Semaglutide Peptide 99% CAS 910463-68-2

    50 MT Nov 13, 2023
    United States

    Semaglutide Powder CAS 910463-68-2 Blood Sugar Regulation

    5 G Aug 3, 2023
    Sri Lanka

    Bulk Supply 98% up Sermaglutide powder CAS 910463-68-2

    300 G Nov 18, 2023
    United States

    Semaglutide Ozempic Sermaglutide 99.9% white powder 910463-68-2 Teruiop

    500 G Oct 9, 2023
    United States

    Raw mateiral Semaglutide CAS 910463-68-2 99% White powder

    1000 G Sep 23, 2023
    United States

    10MG vial pack Semaglutide 99% 910463-68-2 GLP-1 Peptide

    10 MT Oct 18, 2023
    Switzerland

    Semaglutide Ozempic Sermaglutide 99.9% white powder 910463-68-2 Teruiop

    5000 MT Sep 13, 2023
    United States

    High Purity Peptide Semaglutide 910463-68-2 With Safe Shipping

    1 G Sep 7, 2023
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    60 MG Aug 4, 2025
    South Korea

    API Pharmaceutical Chemical Grade Raw Materials CAS 910463-68-2 Semaglutide

    3 G Jul 27, 2023
    China

    Semaglutide Tirzepatide for Weight Loss CAS: 910463-68-2 Retatrutide Cagrilintide

    1 MT Jul 5, 2025
    United States

    API Pharmaceutical Chemical Grade Raw Materials CAS 910463-68-2 Semaglutide

    1 G Jul 26, 2023
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    10 MT Sep 19, 2025
    United States

    High Purity IGF-1 LR3 Peptide CAS 910463-68-2 IGF1 LR3

    Nov 13, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.